Literature DB >> 23198899

Rapid innate control of antigen abrogates adaptive immunity.

Thomas P I Pembroke1, Awen M Gallimore, Andrew Godkin.   

Abstract

Natural killer (NK) cells provide an immediate first line of defence against viral infections. Memory responses, maintained by CD4(+) T cells, require exposure to viral antigen and provide long-term protection against future infections. It is known that NK cells can promote the development of the adaptive response through cytokine production and cross-talk with antigen-presenting cells. In this paper however, we summarize a series of recent publications, in mouse models and for the first time in man, with the unifying message that rapid viral antigen control by the innate immune system limits antigen exposure to CD4(+) cells thereby abrogating the development of a memory response. We discuss the significant implication of these studies on viral treatment strategies and immunization models.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23198899      PMCID: PMC3719940          DOI: 10.1111/imm.12048

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 2.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

3.  Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

Authors:  Jens Dannull; Zhen Su; David Rizzieri; Benjamin K Yang; Doris Coleman; Donna Yancey; Aijing Zhang; Philipp Dahm; Nelson Chao; Eli Gilboa; Johannes Vieweg
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

4.  Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.

Authors:  Katrina Soderquest; Thierry Walzer; Biljana Zafirova; Linda S Klavinskis; Bojan Polić; Eric Vivier; Graham M Lord; Alfonso Martín-Fontecha
Journal:  J Immunol       Date:  2011-02-09       Impact factor: 5.422

5.  Immune tolerance to hepatitis C virus acquired during engraftment of bone marrow transplant.

Authors:  A Godkin; P Openshaw; H C Thomas
Journal:  J Viral Hepat       Date:  2005-11       Impact factor: 3.728

6.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

7.  Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells.

Authors:  Sophie Agaugué; Emanuela Marcenaro; Bruna Ferranti; Lorenzo Moretta; Alessandro Moretta
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

8.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

9.  Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.

Authors:  Tom Pembroke; Ian Rees; Kathleen Gallagher; Emma Jones; Paul Mizen; Timur Navruzov; Andrew Freedman; Ceri Fielding; Ian R Humphreys; Eddie C Y Wang; Awen M Gallimore; Andrew Godkin
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

10.  Tentative T cells: memory cells are quick to respond, but slow to divide.

Authors:  Jason K Whitmire; Boreth Eam; J Lindsay Whitton
Journal:  PLoS Pathog       Date:  2008-04-11       Impact factor: 6.823

View more
  2 in total

1.  In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection.

Authors:  Yoshiaki Takahashi; Siddappa N Byrareddy; Christina Albrecht; Markus Brameier; Lutz Walter; Ann E Mayne; Paul Dunbar; Robert Russo; Dawn M Little; Tara Villinger; Ladawan Khowawisetsut; Kovit Pattanapanyasat; Francois Villinger; Aftab A Ansari
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

2.  Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.

Authors:  Maurizio Melis; Roberto Littera; Eleonora Cocco; Jessica Frau; Sara Lai; Elena Congeddu; Paola Ragatzu; Maria Serra; Valentina Loi; Roberta Maddi; Roberta Pitzalis; Sandro Orrù; Luchino Chessa; Andrea Perra; Carlo Carcassi
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.